U.S. markets closed

ADMA Biologics, Inc. (ADMA)

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Add to watchlist
1.7400+0.1000 (+6.10%)
At close: 4:00PM EDT
Show:
Balance Sheet
Cash Flow
Annual
Subscribe to Yahoo Finance Plus Essential to download historical data

Income Statement

All numbers in thousands
Get access to 40+ years of historical data with Yahoo Finance Plus Essential.Learn more
Breakdown
ttm
12/31/2020
12/31/2019
12/31/2018
12/31/2017
Total Revenue
42,220
42,220
29,349
16,985
22,761
Cost of Revenue
61,291
61,291
39,504
42,195
29,164
Gross Profit
-19,072
-19,072
-10,155
-25,209
-6,404
Operating Expense
45,843
45,843
31,269
35,080
32,061
Operating Income
-64,915
-64,915
-41,424
-60,289
-38,465
Net Non Operating Interest Income Expense
-11,697
-11,697
-8,193
-5,327
-3,229
Other Income Expense
863.269
863.269
1,338
-127.121
-2,066
Pretax Income
-75,749
-75,749
-48,279
-65,743
-43,759
Net Income Common Stockholders
-75,749
-75,749
-48,279
-65,743
-43,759
Diluted NI Available to Com Stockholders
-75,749
-75,749
-48,279
-65,743
-43,759
Basic EPS
-
-
-0.89
-1.45
-1.91
Diluted EPS
-
-
-0.89
-1.45
-1.91
Basic Average Shares
-
-
54,348
45,189
22,896
Diluted Average Shares
-
-
54,348
45,189
22,896
Total Operating Income as Reported
-64,915
-64,915
-41,424
-60,289
-39,310
Total Expenses
107,135
107,135
70,773
77,274
61,225
Net Income from Continuing & Discontinued Operation
-75,749
-75,749
-48,279
-65,743
-43,759
Normalized Income
-76,740
-76,740
-49,844
-65,743
-41,703
Interest Income
288.126
288.126
800.785
195.403
57.228
Interest Expense
11,985
11,985
8,993
5,523
3,286
Net Interest Income
-11,697
-11,697
-8,193
-5,327
-3,229
EBIT
-63,763
-63,763
-39,286
-60,221
-40,473
EBITDA
-59,821
-
-
-
-
Reconciled Cost of Revenue
58,064
58,064
37,091
39,593
27,707
Reconciled Depreciation
3,942
3,942
3,258
3,446
2,692
Net Income from Continuing Operation Net Minority Interest
-75,749
-75,749
-48,279
-65,743
-43,759
Total Unusual Items Excluding Goodwill
991.797
991.797
1,565
0
-2,056
Total Unusual Items
991.797
991.797
1,565
0
-2,056
Normalized EBITDA
-60,813
-60,813
-37,593
-56,774
-35,725
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
0
0
0
0
0